Dr Waleed Brinjikj Joins MIVI Neuroscience as Medical Director

Dr Waleed Brinjikj is an internationally respected interventional neuroradiologist based in Rochester, Minn. He is extensively involved in stroke and neuroendovascular research, with more than 500 peer-reviewed papers and multiple industry and NIH grants, including for a study on improving revascularization techniques in stroke.

Most recently, Dr. Brinjikji was chief medical officer of Marblehead Medical, a Minnesota-based stroke company. He trained at top North American institutions including the University of Toronto and the Mayo Clinic.

As medical director, Dr. Brinjikji will provide MIVI with input and medical guidance across a wide spectrum of its activities, including original clinical research and studies, product design and development, and clinical and customer communications.

“We’re looking forward to Dr. Brinjikji joining our team at this exciting time,” said Bob Colloton, MIVI CEO. “His insights and experience will be invaluable as we continue to achieve our clinical and commercial milestones for our flagship products the Q Aspiration Catheter and DAISe Thrombectomy Device, and identify new business and development opportunities.”

Dr. Brinjikji commented, “The MIVI team shares my passion for improving the lives of patients who suffer an acute ischemic stroke.  I am looking forward to representing MIVI in the neurointerventional community and contributing to the advancement of novel technologies that advance stroke treatment.”

The Q Aspiration Catheter delivers unprecedented aspiration power by optimizing luminal radius and length.  It is CE-marked in Europe and under Investigational Device Exemption in the United States, where it is currently commercially available for distal access.   The DAISe Thrombectomy Device is designed to reduce distal embolization and improve patient outcomes.  It is currently available for investigational use only.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy